246 related articles for article (PubMed ID: 34408546)
1. Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells.
Maliyakkal N; Appadath Beeran A; Udupa N
Saudi Pharm J; 2021 Aug; 29(8):857-873. PubMed ID: 34408546
[TBL] [Abstract][Full Text] [Related]
2. Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells
Zeng F; Wang F; Zheng Z; Chen Z; Wah To KK; Zhang H; Han Q; Fu L
Acta Pharm Sin B; 2020 May; 10(5):799-811. PubMed ID: 32528828
[TBL] [Abstract][Full Text] [Related]
3. Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy
Wu X; Yin C; Ma J; Chai S; Zhang C; Yao S; Kadioglu O; Efferth T; Ye Y; To KK; Lin G
Acta Pharm Sin B; 2021 Jul; 11(7):1885-1902. PubMed ID: 34386326
[TBL] [Abstract][Full Text] [Related]
4. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines.
Youm I; Youan BB
Hear Res; 2013 Oct; 304():7-19. PubMed ID: 23747541
[TBL] [Abstract][Full Text] [Related]
5. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
6. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.
Ruan C; Liu L; Lu Y; Zhang Y; He X; Chen X; Zhang Y; Chen Q; Guo Q; Sun T; Jiang C
Acta Pharm Sin B; 2018 Jan; 8(1):85-96. PubMed ID: 29872625
[TBL] [Abstract][Full Text] [Related]
7. Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2
Zhang Z; Guo X; To KKW; Chen Z; Fang X; Luo M; Ma C; Xu J; Yan S; Fu L
Acta Pharm Sin B; 2018 Jul; 8(4):563-574. PubMed ID: 30109181
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
9. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
10. Fe/Mg-Modified Carbonate Apatite with Uniform Particle Size and Unique Transport Protein-Related Protein Corona Efficiently Delivers Doxorubicin into Breast Cancer Cells.
Haque ST; Karim ME; Abidin SAZ; Othman I; Holl MMB; Chowdhury EH
Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32349272
[TBL] [Abstract][Full Text] [Related]
11. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
12. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
13. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of crocetin into poly (lactic-co-glycolic acid) nanoparticles overcomes drug resistance in human ovarian cisplatin-resistant carcinoma cell line (A2780-RCIS).
Neyshaburinezhad N; Kalalinia F; Hashemi M
Mol Biol Rep; 2019 Dec; 46(6):6525-6532. PubMed ID: 31646427
[TBL] [Abstract][Full Text] [Related]
15. The comparative study of influence of lactic and glycolic acids copolymers type on properties of daunorubicin loaded nanoparticles and drug release.
Nikolskaya E; Sokol M; Faustova M; Zhunina O; Mollaev M; Yabbarov N; Tereshchenko O; Popov R; Severin E
Acta Bioeng Biomech; 2018; 20(1):65-77. PubMed ID: 29658530
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells.
Bhatia P; Bernier M; Sanghvi M; Moaddel R; Schwarting R; Ramamoorthy A; Wainer IW
Xenobiotica; 2012 Aug; 42(8):748-55. PubMed ID: 22401348
[TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
18. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
19. siRNAs targeting multidrug transporter genes sensitise breast tumour to doxorubicin in a syngeneic mouse model.
Tiash S; Chowdhury EH
J Drug Target; 2019 Mar; 27(3):325-337. PubMed ID: 30221549
[TBL] [Abstract][Full Text] [Related]
20. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D
Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
